Innovent's Placing this time makes people feel "uncomfortable", because the Company is actually cash rich. Although Innovent is close to breakeven, its stock price is already high, with limited upside
Boomeranged on Tue, 17 Oct 2023 09:18
Innovent's recent strong share price performance reflects the market's enthusiasm for weight loss drugs. Compared with weight loss pipeline of other domestic companies, IBI362 has more opportunities to become a Me-Better variety. Impending breakeven in financial performance would also be a catalyst. Innovent would have a position in GLP-1s field. Stock price correction is a good buying opportunity
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.